Logo image
Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo
Journal article   Open access   Peer reviewed

Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo

E. Bosio, M.W. Beilharz, M.W. Watson and C.M. Lawson
Journal of Interferon & Cytokine Research, Vol.19(8), pp.869-876
1999
pdf
low-dose_oral_use_of_type_I_interferon.pdfDownloadView
Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

Oral administration of type I interferons (IFNs; murine IFN-α and IFN- β) reduces early replication of murine cytomegalovirus (MCMV) in both the spleen and liver of MCMV-infected BALB/c mice. Examination of a range of doses of IFN (1 to 1000 IU) showed that 10 IU administered daily for 1 week prior to virus infection was optimal for inhibition of MCMV replication. Furthermore, low-dose orally administered IFN (10 IU/day) was effective in mice challenged with lethal and sublethal virus inocula. The antiviral efficacy of low-dose orally administered IFN was not restricted by either the route of virus inoculation or the mouse genotype. Analysis by immunohistochemistry of IFN-α receptor-bearing cells of the gastrointestinal tract revealed predominant staining of perivascular smooth muscle and the lamina propria of the anterior tongue, small intestine and rectum. These tissues, dense in IFN-α receptor-bearing cells, are likely to be the sites of interaction of the orally administered IFNs with the mucosal immune system. In conclusion, we propose that low-dose oral use of type I IFN therapy may have broad applications in the treatment of CMV infections.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

215 File views/ downloads
56 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.6 Immunology
1.6.106 Interferons
Web Of Science research areas
Biochemistry & Molecular Biology
Cell Biology
Immunology
ESI research areas
Immunology
Logo image